Jason S. Buhrman

1.2k total citations · 1 hit paper
16 papers, 938 citations indexed

About

Jason S. Buhrman is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Jason S. Buhrman has authored 16 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Immunology. Recurrent topics in Jason S. Buhrman's work include Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Jason S. Buhrman is often cited by papers focused on Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Jason S. Buhrman collaborates with scholars based in United States, Netherlands and China. Jason S. Buhrman's co-authors include Richard A. Gemeinhart, Jamie Rayahin, Yu Zhang, Timothy J. Koh, Samuel D. Rabkin, Giulia Fulci, Robert L. Martuza, Yu Zhang, Wei Zhang and Martine L.M. Lamfers and has published in prestigious journals such as Radiology, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Jason S. Buhrman

16 papers receiving 926 citations

Hit Papers

High and Low Molecular Weight Hyaluronic Acid Differentia... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason S. Buhrman United States 13 288 181 166 150 148 16 938
Rita Cabral Portugal 19 345 1.2× 217 1.2× 92 0.6× 172 1.1× 119 0.8× 51 1.1k
Tobias May Germany 19 465 1.6× 143 0.8× 165 1.0× 65 0.4× 146 1.0× 43 1.1k
Vincent Ronfard United States 13 582 2.0× 107 0.6× 159 1.0× 177 1.2× 202 1.4× 16 1.6k
Didier Lutomski France 16 356 1.2× 81 0.4× 155 0.9× 66 0.4× 91 0.6× 37 1.0k
Hye Jin Chung United States 17 173 0.6× 80 0.4× 119 0.7× 201 1.3× 77 0.5× 80 1.0k
Michael White United States 13 289 1.0× 66 0.4× 79 0.5× 101 0.7× 93 0.6× 19 987
Nicole L. Rosin Canada 19 467 1.6× 68 0.4× 121 0.7× 110 0.7× 109 0.7× 34 1.4k
Corrie L. Gallant‐Behm Canada 21 545 1.9× 66 0.4× 105 0.6× 132 0.9× 129 0.9× 30 1.6k
Gwang Seong Choi South Korea 18 199 0.7× 111 0.6× 76 0.5× 282 1.9× 108 0.7× 96 1.4k
Cecelia C. Yates United States 21 476 1.7× 57 0.3× 180 1.1× 162 1.1× 182 1.2× 37 1.6k

Countries citing papers authored by Jason S. Buhrman

Since Specialization
Citations

This map shows the geographic impact of Jason S. Buhrman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason S. Buhrman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason S. Buhrman more than expected).

Fields of papers citing papers by Jason S. Buhrman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason S. Buhrman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason S. Buhrman. The network helps show where Jason S. Buhrman may publish in the future.

Co-authorship network of co-authors of Jason S. Buhrman

This figure shows the co-authorship network connecting the top 25 collaborators of Jason S. Buhrman. A scholar is included among the top collaborators of Jason S. Buhrman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason S. Buhrman. Jason S. Buhrman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jaishankar, Dinesh, Jason S. Buhrman, Tibor Vályi-Nagy, Richard A. Gemeinhart, & Deepak Shukla. (2016). Extended Release of an Anti–Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection. Investigative Ophthalmology & Visual Science. 57(1). 169–169. 40 indexed citations
2.
Zhang, Yu, Jason S. Buhrman, Yang Liu, Jamie Rayahin, & Richard A. Gemeinhart. (2016). Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid. Molecular Pharmaceutics. 13(6). 1791–1799. 18 indexed citations
3.
Rayahin, Jamie, Jason S. Buhrman, Yu Zhang, Timothy J. Koh, & Richard A. Gemeinhart. (2015). High and Low Molecular Weight Hyaluronic Acid Differentially Influence Macrophage Activation. ACS Biomaterials Science & Engineering. 1(7). 481–493. 480 indexed citations breakdown →
4.
Farrar, Christian T., Jason S. Buhrman, Guanshu Liu, et al.. (2015). Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy. Radiology. 275(3). 746–754. 61 indexed citations
5.
Rayahin, Jamie, Jason S. Buhrman, & Richard A. Gemeinhart. (2014). Melittin–glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity. European Journal of Pharmaceutical Sciences. 65. 112–121. 15 indexed citations
6.
Zhang, Yu, et al.. (2014). Arginine-rich, cell penetrating peptide–anti-microRNA complexes decrease glioblastoma migration potential. Peptides. 58. 83–90. 25 indexed citations
7.
Buhrman, Jason S., Jamie Rayahin, Laura C. Cook, Michael J. Federle, & Richard A. Gemeinhart. (2013). Active, soluble recombinant melittin purified by extracting insoluble lysate of Escherichia coli without denaturation. Biotechnology Progress. 29(5). 1150–1157. 9 indexed citations
8.
Buhrman, Jason S., Laura C. Cook, Jamie Rayahin, Michael J. Federle, & Richard A. Gemeinhart. (2013). Proteolytically activated anti-bacterial hydrogel microspheres. Journal of Controlled Release. 171(3). 288–295. 12 indexed citations
9.
Buhrman, Jason S., et al.. (2013). Markers are shared between adipogenic and osteogenic differentiated mesenchymal stem cells. PubMed. 5(2). 18–25. 55 indexed citations
10.
Zhang, Wei, Giulia Fulci, Hiroaki Wakimoto, et al.. (2013). Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models. Neoplasia. 15(6). 591–599. 67 indexed citations
11.
Rayahin, Jamie, Jason S. Buhrman, & Richard A. Gemeinhart. (2012). Hybrid nanocrystals: University of Kentucky US20060280680A1. Expert Opinion on Therapeutic Patents. 22(3). 341–348. 4 indexed citations
12.
Buhrman, Jason S., et al.. (2012). In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins. BMC Biotechnology. 12(1). 63–63. 7 indexed citations
13.
Kleijn, Anne, John W. Chen, Jason S. Buhrman, et al.. (2011). Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging. Clinical Cancer Research. 17(13). 4484–4493. 29 indexed citations
14.
Zhang, Wei, Giulia Fulci, Jason S. Buhrman, et al.. (2011). Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma. Molecular Therapy. 20(1). 37–45. 57 indexed citations
15.
Castelo‐Branco, Pedro, Brent J. Passer, Jason S. Buhrman, et al.. (2010). Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer. Gene Therapy. 17(6). 805–810. 27 indexed citations
16.
Passer, Brent J., Pedro Castelo‐Branco, Jason S. Buhrman, et al.. (2009). Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells. Cancer Gene Therapy. 16(7). 551–560. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026